Shandong Jincheng Pharmaceutical Group Co., Ltd (SHE:300233)

China flag China · Delayed Price · Currency is CNY
15.12
-0.17 (-1.11%)
At close: Feb 13, 2026
Market Cap5.74B +20.1%
Revenue (ttm)2.79B -19.9%
Net Income77.30M -60.0%
EPS0.20 -61.2%
Shares Out379.33M
PE Ratio76.52
Forward PEn/a
Dividend0.30 (1.98%)
Ex-Dividend DateSep 17, 2025
Volume3,942,299
Average Volume7,793,042
Open15.23
Previous Close15.29
Day's Range15.08 - 15.34
52-Week Range12.65 - 23.22
Beta0.53
RSI46.48
Earnings DateMar 27, 2026

About SHE:300233

Shandong Jincheng Pharmaceutical Group Co., Ltd researches and develops, produces, markets, and sells Cephalosporin intermediates in China and internationally. It offers medical intermediate, animal nutrition, health care, CMO, CDMO, pharmaceuticals, API, finished dosage, and fine chemicals. Shandong Jincheng Pharmaceutical Group Co., Ltd was founded in 2004 and is based in Zibo, China. [Read more]

Industry Chemicals
Sector Materials
Founded 2004
Employees 3,657
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300233
Full Company Profile

Financial Performance

In 2024, SHE:300233's revenue was 3.37 billion, a decrease of -4.66% compared to the previous year's 3.54 billion. Earnings were 196.78 million, an increase of 12.63%.

Financial Statements